❓ Hon. Sophia Moermond asks about the presence and detection of drugs marketed as 2C-B in WA, following a concerning news report. The Minister for Mental Health responds that it hasn't been detected in hospitals and outlines existing monitoring and information dissemination processes.
AnsweredQoN 508Legislative Council
QuestionView source ↗
2C-B
508. Hon SOPHIA MOERMOND to the Leader of the House
representing the Minister for Mental Health:
I
refer to the ABC news report today that a drug recently tested by the CanTEST
Health and Drug Checking Service and marketed and sold as 2C-B—the
chemical name is 4-Bromo-2,5-dimethoxyphenethylamine—a psychedelic
drug, was in fact found to be a potentially deadly concoction of MDMA, ketamine
and cocaine.
(1) Has the drug
2C-B, or any concoction of drugs marketed as 2C-B, been detected in Western Australia?
(2) Does the
government have any safeguards in place to detect this drug in the community
before it results in hospitalisation or death?
508. Hon SOPHIA MOERMOND to the Leader of the House
representing the Minister for Mental Health:
I
refer to the ABC news report today that a drug recently tested by the CanTEST
Health and Drug Checking Service and marketed and sold as 2C-B—the
chemical name is 4-Bromo-2,5-dimethoxyphenethylamine—a psychedelic
drug, was in fact found to be a potentially deadly concoction of MDMA, ketamine
and cocaine.
(1) Has the drug
2C-B, or any concoction of drugs marketed as 2C-B, been detected in Western Australia?
(2) Does the
government have any safeguards in place to detect this drug in the community
before it results in hospitalisation or death?
AnswerView source ↗
I thank the honourable member for
some notice of the question.
(1) No; 2C-B has
not been detected in Western Australian hospitals. There are no anecdotal
reports of 2C-B being marketed in Western Australia.
(2) The Mental
Health Commission receives early advice on emerging drugs of concern through
state and national networks. The Mental Health Commission provides information
about potential harms, what to look for in
users—signs and symptoms—and the appropriate treatment response
to relevant frontline services.
some notice of the question.
(1) No; 2C-B has
not been detected in Western Australian hospitals. There are no anecdotal
reports of 2C-B being marketed in Western Australia.
(2) The Mental
Health Commission receives early advice on emerging drugs of concern through
state and national networks. The Mental Health Commission provides information
about potential harms, what to look for in
users—signs and symptoms—and the appropriate treatment response
to relevant frontline services.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.